Among the many disparities and inequities that COVID-19 has shone a light upon, the chasm in health outcomes between rich and poor countries is being particularly sharply highlighted. While Israel, the US, the UK, and a handful of high- and upper-middle income countries are charging forward with their vaccination programmes, many of the poorest are left behind—sometimes to rapidly soaring infection rates, as in India. Universal health—that is, a basic level of health and nutrition achieved globally—seems a distant prospect.
CGD Policy Blogs
The COVID-19 pandemic has cost lives and disrupted economic activity worldwide. It has impacted government budgets globally by reducing tax receipts and increasing spending on programs to save lives and transfer income to those adversely affected by the pandemic.
Making the $12 Billion Go Further: Four Things the World Bank Can Do in Support of COVID-19 Vaccination Efforts
To maximise the impact of this badly needed investment to combat COVID and, most importantly, to avoid any perverse and potentially catastrophic implications of World Bank financing undermining current global efforts led by Gavi and CEPI, we propose that the World Bank commit to the four principles below.
As low- and middle-income countries are hit by the health and economic effects of COVID-19, the international community is working to mobilize billions of dollars in grants, loans, and debt relief. At the moment, it is difficult to get a full picture of the funding on offer, to whom it is given, and how it will be used.
DFIs are well positioned to address five pressure points in the COVID-19 response that need financing. Let’s unpack these one by one.
Virtually all countries in the world have responded to the COVID-19 crisis by implementing fiscal and monetary measures, significantly larger in relation to national output than those employed during the 2008 financial crisis. The magnitude of fiscal measures to counter the shock varies across developing and advanced economies.
Poor quality medicines pose significant risks to global health. This blog responds to a recent report from the National Academies that out clear recommendations to global, national and agency level stakeholders which can help strengthen food and medical products regulatory systems in low- and middle-income countries.
The US and China Have Very Different Takes on IDA and the Global Fund: Why that Matters for the Future of Multilateral Aid
When it comes to the United States, the reality is that the Global Fund is winning the fundraising game hands down. China, meanwhile, doubled its contribution to IDA—contrast that with the country’s longstanding indifference to the Global Fund. Clearly the world’s most important emerging donor views the multilateral architecture differently than the world’s most important traditional donor does.
What’s the Latest Economics Research on Africa? A Round-up from the Center for the Study of African Economies 2019 Conference
Last week’s annual Center for the Study of African Economies (CSAE) conference brought together researchers from the African continent and around the world for the presentation of nearly 300 papers about nearly every aspect of African societies, from agriculture to education to firms to health to trade. Here I provide a micro-summary of almost every paper presented at the conference.
In 2019, major sources of concessional finance—the big global health funders like the Global Fund and Gavi, as well as the development-bank-based IDA and the African Development Fund—will ask donors for more money to accomplish more health and development.